The World Anti-Doping Agency classifies HGH under its peptide hormones, growth factors, and related substances category, prohibited both in and out of competition. Year-round prohibition reflects the fact that GH's performance-related effects and detectable window extend well beyond event days, unlike substances restricted only on competition day.
Virtually every major sporting body that follows the WADA code, including national federations in the UAE, applies this same classification, making HGH one of the more consistently and strictly regulated substances across international sport.
Detecting exogenous HGH use posed an analytical challenge that many other banned substances did not, because pharmaceutical HGH is structurally identical to the hormone the body produces naturally. A standard drug test that simply looks for the presence of the molecule cannot easily distinguish an athlete's own GH from an injected pharmaceutical dose.
This structural identity problem meant early anti-doping efforts had to develop entirely new analytical approaches rather than adapting existing drug-screening methods, a challenge distinct from detecting synthetic substances with no natural counterpart in the body.
Anti-doping laboratories addressed this by developing isoform-ratio tests, which exploit subtle differences between the various molecular forms of GH the pituitary naturally releases versus the more uniform recombinant pharmaceutical product, detecting a shift in the natural ratio after exogenous use.
A complementary biomarker-based approach instead measures downstream effects of GH exposure — substances like IGF-1 that change measurably following GH administration — rather than trying to detect the hormone itself. Both approaches have continued to be refined over the history of anti-doping testing.
This detection history illustrates a recurring theme in anti-doping science: substances structurally identical to natural hormones require fundamentally different testing strategies than synthetic compounds, and HGH has been a significant driver of analytical innovation in the field for this reason.
This is general anti-doping regulatory and scientific history, not medical or legal advice for athletes. REVIVE LAB UAE does not sell HGH, does not advise on doping-related matters, and takes no position on any individual case.